
MDCG Guidance on Borderline Between Medical Devices and Medicinal Products: Combinations
The final article of the cycle is dedicated to combination products and their specific regulatory nature.
The final article of the cycle is dedicated to combination products and their specific regulatory nature.
The European Union Medical Device Regulation (EU MDR) significantly reshaped the landscape for medical device manufacturers, introducing stringent regulatory requirements aimed at enhancing patient safety and device efficacy. Enforced since May 2021, the MDR replaced the older Medical Device Directive (MDD), demanding greater transparency and accountability from manufacturers operating within the EU market.
The new article further describes the applicable regulatory considerations, paying additional attention to the key concepts used in the context of borderline products in order to ensure the relevant regulations are applied properly.
Navigating the complex landscape of global medical device regulations can be a daunting task for regulatory professionals and medical device companies. With each country enforcing its own set of rules and standards, ensuring compliance across multiple markets requires a strategic approach and in-depth knowledge. This guide aims to provide you with key insights and strategies to master multi-country medical device regulations, helping you expand your market reach effectively and confidently.
In today’s rapidly evolving regulatory landscape, medical device companies face increasingly complex challenges in bringing their products to market and maintaining compliance across multiple jurisdictions. The good news is that technological advancements, particularly in artificial intelligence (AI), machine learning (ML), and automation, are revolutionizing the field of regulatory affairs. These innovations are not just buzzwords; they’re powerful tools that can streamline workflows, reduce errors, and significantly accelerate time-to-market for medical devices.
The new article describes in detail certain specific aspects to be taken into consideration by the parties involved in order to ensure the important information is duly communicated in accordance with the relevant regulatory requirements.